In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Randomized Controlled Clinical Trial Evaluating the Safety & Effectiveness of 10 kHz High Frequency & Traditional Low Frequency Stimulation for the Treatment of Chronic Back & Leg Pain: 1

    Final Number:
    188

    Authors:
    L. Kapural; C. Yu; M. Doust; B. Gliner; R. Vallejo; B. Sitzman; K. Amirdelfan; D. Morgan; L. Brown; T. Yearwood.; R. Bundschu; A. Burton; T. Yang; R. Benyamin; A. Burgher

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2015 Annual Meeting

    Introduction: A randomized controlled trial with appropriate statistical power and long term outcomes is the hallmark of Level 1 clinical evidence. The SENZA-RCT multi-center pivotal study was powered to directly compare high frequency spinal cord stimulation (SCS) at 10 kHz (HF10™ therapy) and traditional low frequency (~50 Hz) SCS. The comparative efficacy of these modalities for the treatment of chronic back and leg pain for 18 months is presented.

    Methods: Baseline assessments were performed prior to randomization of 198 patients. 171 patients responded during a trial phase of the assigned SCS system and were implanted. 18 month results were available for 165 of these patients. Responders were defined as having at least 50% pain reduction, while pain remitters were defined as having a VAS pain score of 2.5 or less out of 10.

    Results: At 18 months, back pain decreased to a greater degree for patients receiving HF10 therapy (64.9%±30.8%) than with traditional SCS (42.5%±35.9%), p<0.001. Similarly, leg pain decreased to a greater degree for HF10 therapy patients (65.4%±35.2%) than with traditional SCS (45.0%±40.3%), p<0.001. More patients were pain responders to HF10 therapy than traditional SCS (Back pain: 75.9% for HF10 therapy, 47.7% for traditional SCS, p<0.001; Leg pain: 77.0% for HF10 therapy, 53.8% for traditional SCS, p<0.001). More patients were also pain remitters with HF10 therapy than traditional SCS (Back pain: 62.1% for HF10 therapy, 30.8% for traditional SCS, p<0.001; Leg pain: 64.4% for HF10 therapy, 38.5% for traditional SCS, p<0.001). Patients classified as remitters in both groups combined had a back pain score of 1.2±0.8 and a leg pain score of 1.0±0.8. Safety profiles were similar.

    Conclusions: The SENZA-RCT study provides strong Level 1 evidence in support of long-term use HF10 therapy as compared with traditional low-frequency SCS for the treatment of chronic back and leg pain.

    Patient Care: Provide physicians with long-term Level 1 evidence supporting the safety and efficacy of spinal cord stimulation for the treatment of chronic back and leg pain.

    Learning Objectives: 1. Understand the differences between 10 kHz high frequency and traditional low frequency (~50 Hz) spinal cord stimulation 2. Understand the comparative safety and efficacy these to SCS modalities in treating chronic back and leg pain over an 18 month period.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy